Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting

Cancer Research

Volumn 67, Issue 3, 2007, Pages 854-855

  Dewhirst, Mark W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN;

CANCER RADIOTHERAPY; CELL GROWTH; CELL SURVIVAL; CHRONIC DISEASE; HUMAN; HYPOXIA; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; VASCULAR ENDOTHELIUM;

CELL HYPOXIA; ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOPLASMS; OXYGEN; PARTIAL PRESSURE;

EID: 33847023140     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-4744     Document Type: Review

References (15)

1. Yamaura H, Matsuzawa T. Tumor regrowth after irradiation; an experimental approach. Int J Radiat Biol Relat Stud Phys Chem Med 1979;35:201-19.
2. Brown JM. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 1979;52:650-6.
3. Hill SA, Chaplin DJ. Detection of microregional fluctuations in erythrocyte flow using laser Doppler microprobes. Adv Exp Med Biol 1996;388:367-71.
4. Pigott KH, Hill SA, Chaplin DJ, Saunders MI. Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry. Radiother Oncol 1996;40:45-50.
5. Dewhirst MW, Kimura H, Rehmus SW, et al. Microvascular studies on the origins of perfusion-limited hypoxia. Br J Cancer Suppl 1996;27:S247-51.
6. Kimura H, Braun RD, Ong ET, et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 1996;56:5522-8.
7. Lanzen J, Braun RD, Klitzman B, Brizel D, Secomb TW, Dewhirst MW. Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res 2006;66:2219-23.
8. 2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. Radiother Oncol 2005;77:220-6.
9. Sorg BS, Moeller BJ, Donovan O, Cao Y, Dewhirst MW. Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development J Biomed Opt 2005;10:44004.
10. Bennewith KL, Durand RE. Quantifying transient hypoxia in human tumor xenografts by flow cytometry. Cancer Res 2004;64:6183-9.
11. Zakrzewicz A, Secomb TW, Pries AR. Angioadaptation: keeping the vascular system in shape. News Physiol Sci 2002;17:197-201.
12. Moeller BJ, Cao Y, Li CY, Dewhirst MW. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004;5:429-41.
13. Moeller BJ, Dreher MR, Rabbani ZN, et al. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 2005;8:99-110.
14. Martinive P, Defresne F, Bouzin C, et al. Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. Can Res 2006;66:11736-44.
15. Giaccia A, Siim BG, Johnson RS. HIF-1 as a target for drug development Nat Rev Drug Discov 2003;2:803-11.